David Dasberg MD

David Dasberg is the Managing Director of Facio Therapies and Facio Intellectual Property. He has over 20 years' experience with the development and commercialization of (bio)pharmaceutical products. As an independent consultant, David performed a feasibility study commissioned by the Dutch FSHD Foundation that laid the basis for the Facio group of companies. Prior, David held business development positions of increasing responsibility at Pharming Group and Fresenius Kabi.